BioLife Solutions, Inc.
NASDAQ:BLFS · NASDAQ Capital Market
+$0.40 today
Vol 1.06M · Avg 0.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+21.91%
Period High
$28.79
Period Low
$18.15
Latest
$26.04
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Establishment Labs Holdings Inc.
NASDAQ:ESTA
$2.51B
Neogen Corporation
NASDAQ:NEOG
$1.98B
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.81B
NovoCure Limited
NASDAQ:NVCR
$1.71B
Harrow Health, Inc.
NASDAQ:HROW
$1.56B
STAAR Surgical Company
NASDAQ:STAA
$1.43B
AtriCure, Inc.
NASDAQ:ATRC
$1.42B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.11B
Azenta, Inc.
NASDAQ:AZTA
$1.05B
Phreesia, Inc.
NYSE:PHR
$581.65M
What is the latest BLFS filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does BLFS have?
Intrinsic Alpha currently shows 20 recent filings for BLFS.
Explore More
Continue the stock analysis
Jump to another research area for this company.